Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact
- PMID: 36931289
- PMCID: PMC10420388
- DOI: 10.1016/S0140-6736(23)00001-6
Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact
Abstract
The Global Diabetes Compact is a WHO-driven initiative uniting stakeholders around goals of reducing diabetes risk and ensuring that people with diabetes have equitable access to comprehensive, affordable care and prevention. In this report we describe the development and scientific basis for key health metrics, coverage, and treatment targets accompanying the Compact. We considered metrics across four domains: factors at a structural, system, or policy level; processes of care; behaviours and biomarkers such as glycated haemoglobin (HbA1c); and health events and outcomes; and three risk tiers (diagnosed diabetes, high risk, or whole population), and reviewed and prioritised them according to their health importance, modifiability, data availability, and global inequality. We reviewed the global distribution of each metric to set targets for future attainment. This process led to five core national metrics and target levels for UN member states: (1) of all people with diabetes, at least 80% have been clinically diagnosed; and, for people with diagnosed diabetes, (2) 80% have HbA1c concentrations below 8·0% (63·9 mmol/mol); (3) 80% have blood pressure lower than 140/90 mm Hg; (4) at least 60% of people 40 years or older are receiving therapy with statins; and (5) each person with type 1 diabetes has continuous access to insulin, blood glucose meters, and test strips. We also propose several complementary metrics that currently have limited global coverage, but warrant scale-up in population-based surveillance systems. These include estimation of cause-specific mortality, and incidence of end-stage kidney disease, lower-extremity amputations, and incidence of diabetes. Primary prevention of diabetes and integrated care to prevent long-term complications remain important areas for the development of new metrics and targets. These metrics and targets are intended to drive multisectoral action applied to individuals, health systems, policies, and national health-care access to achieve the goals of the Global Diabetes Compact. Although ambitious, their achievement can result in broad health benefits for people with diabetes.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests WHO provided financial support and two affiliated advisers contributed as authors. EWG and JB report receiving consultation funding from WHO related to this work. EWG also receives funding from UK Royal Society and Science Foundation Ireland. Authors report the following funding unrelated to this study and report: MKA reports funding from Merck, Bayer, and Eli Lilly; RM reports consulting fees from Novo Nordisk, Eli Lilly, Boeheringer Ingelheim, Sanofi, and AstraZeneca; L-LL reports grants or honoraria from AstraZeneca, Boeheringer Ingelheim, Abbott, Merck Sharp & Dohme, Sanofi, Servier, Zuellig Pharma, and Pfizer; JPS reports funding from Novo Nordisk and Pfizer; JES reports funding from AstraZeneca, Sanofi, Novo Nordisk, MSD, Eli Lilly, and Pfizer, Mylan, Sanofi, Boehringer Ingelheim, and Zuellig Pharma. All other authors declare no competing interests.
Figures


Comment in
-
Recommendations from 'Improving health outcomes of people with diabetes: Target setting for the WHO Global Diabetes Compact' for the Indian context: Laudable but are they achievable?Natl Med J India. 2023 Sep-Oct;36(5):281-282. doi: 10.25259/NMJI_713_2023. Natl Med J India. 2023. PMID: 38759989 No abstract available.
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Tuberculosis.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
-
The 2023 Latin America report of the Lancet Countdown on health and climate change: the imperative for health-centred climate-resilient development.Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May. Lancet Reg Health Am. 2024. PMID: 38800647 Free PMC article. Review.
-
Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.Health Technol Assess. 2020 Jun;24(28):1-232. doi: 10.3310/hta24280. Health Technol Assess. 2020. PMID: 32568666 Free PMC article.
-
The effectiveness of physical leisure time activities on glycaemic control in adult patients with diabetes type 2: A Systematic Review.JBI Libr Syst Rev. 2012;10(42 Suppl):1-20. doi: 10.11124/jbisrir-2012-251. JBI Libr Syst Rev. 2012. PMID: 27820154
Cited by
-
The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) as a predictor of all-cause and cardiovascular mortality in US adults with diabetes or prediabetes: NHANES 1999-2018.BMC Med. 2024 Aug 7;22(1):317. doi: 10.1186/s12916-024-03536-3. BMC Med. 2024. PMID: 39113030 Free PMC article.
-
Mind the gap in kidney care: translating what we know into what we do.Kidney Res Clin Pract. 2025 Jan;44(1):6-19. doi: 10.23876/j.krcp.24.100. Epub 2025 Jan 15. Kidney Res Clin Pract. 2025. PMID: 39815796 Free PMC article.
-
Unravelling the association of glycosylated haemoglobin A1c, blood pressure, and LDL-cholesterol (ABC) with all-cause mortality in Type 2 diabetes patients: insights from a middle-income country.J Diabetes Metab Disord. 2025 Apr 30;24(1):111. doi: 10.1007/s40200-025-01620-w. eCollection 2025 Jun. J Diabetes Metab Disord. 2025. PMID: 40321425
-
Social determinants of health and diabetes: using a nationally representative sample to determine which social determinant of health model best predicts diabetes risk.Clin Diabetes Endocrinol. 2024 Feb 25;10(1):4. doi: 10.1186/s40842-023-00162-5. Clin Diabetes Endocrinol. 2024. PMID: 38402223 Free PMC article.
-
Mind the Gap in Kidney Care: Translating What We Know into What We Do.Blood Purif. 2024;53(9):691-703. doi: 10.1159/000539071. Epub 2024 May 16. Blood Purif. 2024. PMID: 38754386 Free PMC article. No abstract available.
References
-
- Federation ID. IDF Diabetes Atlas. 2021. www.diabetesatlas.org.
-
- Chan JCN, Lim LL, Wareham NJ, et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet 2021; 396(10267): 2019–82. - PubMed
-
- Williams R, Karuranga S, Malanda B, et al. Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2020; 162: 108072. - PubMed
-
- Bommer C, Heesemann E, Sagalova V, et al. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol 2017; 5(6): 423–30. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous